Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
Netherlands
Psma-1007 (18 f)

CBG-MEB 2023

Psma-1007 (18 f)

Radelumin 1300 MBq/ml oplossing voor injectie

Oplossing voor injectieNetherlandsAuthorisedAuthorised 4 Apr 2023

Product informationAsk Osler about it

On this page

In other countries
Documents
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

Radelumin 1300 MBQ/ML Solucion InyectableSpain · 1300 MBq/ml · solución inyectable · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbhSame brand
Radelumin 2000 MBQ/ML Solucion InyectableSpain · 2000 MBq/ml · solución inyectable · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GmbhSame brand
RadeluminItaly · Soluzione iniettabile · Abx Advanced Biochemical Compounds Biomedizinische Forschungsreagenzien GMBHSame brand
ProstaluminCanada · 3.7 GBQ / ML · Solution · Centre for Probe Development and CommercializationSame substance

Documents

The official texts, at the regulator.

Summary of product characteristics

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

CBG-MEB

Package leafletCBG-MEB

Register entryCBG-MEB

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Psma-1007 (18 f)
Dosage form: Oplossing voor injectie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 4 Apr 2023
Registration: 130642
Marketing authorisation holder: ABX advanced biochemical compounds, Biomedizinische Forschungsreagenzien GmbH
ATC code: V09IX17
Group: Various
Procedure: National (RVG)
Supply: Uitsluitend recept